These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3113943)

  • 1. Lack of cross-resistance between imipenem and other beta-lactam antibiotics for Pseudomonas aeruginosa.
    Opferkuch W; Cullmann W
    Eur J Clin Microbiol; 1987 Jun; 6(3):330-2. PubMed ID: 3113943
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to imipenem in Pseudomonas aeruginosa.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1995 Dec; 36(6):1037-41. PubMed ID: 8821603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosa.
    Giacometti A; Siquini FM; Cirioni O; Petroni S; Scalise G
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):315-8. PubMed ID: 8070438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-induced resistance to beta-lactams in Pseudomonas aeruginosa.
    Giacometti A; Del Prete MS; Cirioni O; Izat MK; Balducci M; Cesarini AM; Scalise G
    J Chemother; 1995 Nov; 7 Suppl 4():76-7. PubMed ID: 8904115
    [No Abstract]   [Full Text] [Related]  

  • 5. Imipenem resistance in Pseudomonas aeruginosa is due to diminished expression of outer membrane proteins.
    Büscher KH; Cullmann W; Dick W; Wendt S; Opferkuch W
    J Infect Dis; 1987 Oct; 156(4):681-4. PubMed ID: 3114392
    [No Abstract]   [Full Text] [Related]  

  • 6. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein.
    Büscher KH; Cullmann W; Dick W; Opferkuch W
    Antimicrob Agents Chemother; 1987 May; 31(5):703-8. PubMed ID: 3111361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selection of resistant variants by broad spectrum beta-lactam antibiotics: to what extent is there cross resistance between imipenem and other beta-lactam antibiotics?].
    Kahan F; Kropp H
    Immun Infekt; 1986 Nov; 14(6):232-5. PubMed ID: 3100429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
    Stratton CW; Weeks LS; Tausk F
    J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey.
    Bonfiglio G; Carciotto V; Russo G; Stefani S; Schito GC; Debbia E; Nicoletti G
    J Antimicrob Chemother; 1998 Feb; 41(2):307-10. PubMed ID: 9533479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-resistance and imipenem.
    Calandra G; Ricci F; Wang C; Brown K
    Lancet; 1986 Aug; 2(8502):340-1. PubMed ID: 2874348
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of ceftazidime and N-formimidoyl thienamycin against gentamicin-susceptible and resistant Pseudomonas aeruginosa.
    Alford RH
    J Antimicrob Chemother; 1983 Jun; 11(6):599-601. PubMed ID: 6411675
    [No Abstract]   [Full Text] [Related]  

  • 12. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. En bloc transduction of imipenem resistance with other resistance determinants from a clinical strain of Pseudomonas aeruginosa.
    Babálová M; Blahová J; Hupková-Lesická M; Krcméry V; Schäfer V
    J Chemother; 1996 Feb; 8(1):43-6. PubMed ID: 8835107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosa.
    Bertram MA; Young LS
    Antimicrob Agents Chemother; 1984 Aug; 26(2):272-4. PubMed ID: 6435517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion.
    Gotoh N; Nishino T
    J Antimicrob Chemother; 1990 Feb; 25(2):191-8. PubMed ID: 2109748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
    Weinstein RA; Nathan C; Delzell D; Kabins SA
    Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of resistance to imipenem among nosocomial isolates of Pseudomonas aeruginosa.
    Başustaoğlu AC; Gün H; Saraçli MA; Baysallar M; Haznedaroğlu T
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):469-70. PubMed ID: 7556242
    [No Abstract]   [Full Text] [Related]  

  • 19. Postantibiotic effect of imipenem, alone and in combination with amikacin, on Pseudomonas aeruginosa.
    Gerçeker AA; Otük G
    Chemotherapy; 1995; 41(6):433-6. PubMed ID: 8529433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.
    Dixson S; Andrew JH
    Pathology; 1985 Oct; 17(4):636-9. PubMed ID: 3938006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.